← SynDRA
abarelix
SynDRA canonical compound SYN0041818 — structure-anchored drug synonym record
| Clinical phase | Phase 3 |
| Primary target(s) | GNRH1 | GNRHR |
| Mechanism of action | gonadotropin releasing factor hormone receptor antagonist |
All known targets
Mechanisms of action (all sources)
- GNRHR ANTAGONIST
- Gonadotropin-releasing hormone receptor antagonist
- gonadotropin releasing factor hormone receptor antagonist
- GNRHR MODULATOR
Drug classes
ATC classes
- L02B · HORMONE ANTAGONISTS AND RELATED AGENTS
Cross-references
Synonyms
- plenaxis
- PPI-149
- R3827
- R-382
- R-3827
- R382
- Plenaxis
- Abarelix [USAN]
- Plenaxis depot
- Plenaxis (TN)
- Abarelix (USAN/INN)
- Abarelix-Depot-M
- N-Acetyl-3-(2-naphthyl)-D-alanyl-4-chloro-D-phenylalanyl-3-(3-pyridyl)-D-alanyl-L-seryl-N-methyl-L-tyrosyl-D-asparginyl-L-leucyl-N6-isopropyl-L-lysyl-L-prolyl-D-alaninamide
- N-Acetyl-3-(2-naphthyl)-D-alanyl-4-chloro-D-phenylalanyl-3-(3-pyridyl)-D-alanyl-L-seryl-N-methyl-L-tyrosyl-D-asparaginyl-L-leucyl-N(sup 6)-isopropyl-L-lysyl-L-prolyl-D-alaninamide
- N-acetyl-3-(2-naphthyl)-D-alanyl-4-chloro-D-phenylalanyl-3-(pyridin-3-yl)-D-alanyl-L-seryl-N-methyl-L-tyrosyl-D-asparginyl-L-leucyl-N(6)-isopropyl-L-lysyl-L-prolyl-D-alaninamide
- D-Alaninamide, N-acetyl-3-(2-naphthalenyl)-D-alanyl-4-chloro-D-phenylalanyl-3-(3-pyridinyl)-D-alanyl-L-seryl-N-methyl-L-tyrosyl-D-asparaginyl-L-leucyl-N6-(1-methylethyl)-L-lysyl-L-prolyl-10
- PPI 149
- R 3827
- CHEBI:337298
- W486SJ5824
- abarelixum
- RefChem:58461
- DTXCID4093934
- L02XB01
- Abarelix Acetate
- PPI149
- Abarelix Trifluoroacetate Salt (~90%)
- Abarelix [USAN:INN]
- C72H95ClN14O14
- UNII-W486SJ5824
- SCHEMBL9533
- GTPL1188
- orb1310028
- SCHEMBL7636736
- SCHEMBL29393243
- SCHEMBL29405669
- AIWRTTMUVOZGPW-HSPKUQOVSA-N
- Abarelix acetate - Bio-X trade mark
Look up abarelix in the interactive SynDRA portal →